New Drug Delivery Systems Concept in Anaesthesia and Intensive Care—Controlled Release of Active Compounds

Open access


With time, medical and pharmaceutical research has advanced significantly. However, one of the major issues is how to administer the active substance. Among these, it counts over- or under-dosage of the active substance, low re­sponse to treatment, or increased clinical risk of the patient. An innovative method able to avoid these obstacles is represented by controlled release systems for active substances. The interest for these systems came with allowing encapsulation in the antibiotic release matrices, local anesthetics, protein or other substances. Moreover, a number of such vehicles are now available to release controlled substances used predominantly in the anesthesia and intensive care unit.

1. Zhang Y, Chan HF, Leong KW. Advanced materials and processing for drug delivery: the past and the future. Adv Drug Deliv Rev 2013; 65:104-120

2. Mrsny RJ. Oral drug delivery research in Europe. J Control Release 2012; 161:247-253

3. Webster DM, Sundaram P, Byrne ME. Injectable nanomaterials for drug delivery: carriers, targeting moieties, and therapeutics. Eur J Pharm Biopharm 2013; 84:1-20

4. Ukmar T, Maver U, Planinšek O, Kaučič V, Gaberšček M, Godec A. Understanding controlled drug release from mesoporous silicates: Theory and experiment. Journal of Controlled Release 2011; 155:409-417

5. Rana S, Bajaj A, Mout R, Rotello VM. Monolayer coated gold nanoparticles for delivery applications. Adv Drug Deliv Rev 2012; 64:200-216

6. Castro E, Mosquera V, Katime I. Dual Drug Release of Triamterene and Aminophylline from Poly(N-isopropylacrylamide) Hydrogels. Nanomater Nanotechnol 2012; 2:1-9

7. Robeiro LN, Alcântara AC, Darder M, Aranda P, Araújo-Moreira FM, Ruiz-Hitzky E. Pectin-coated chitosan-LDH bionanocomposite beads as potential systems for colon-targeted drug delivery. Int J Pharm 2014; 463:1-9

8. Wang C, Ye W, Zheng Y, Liu X, Tong Z. Fabrication of drug-loaded biodegradable microcapsules for controlled release by combination of solvent evaporation and layer-by-layer self-assembly. Int J Pharm 2007; 338:165-173

9. Ma J, Zhang M, Lu L, Yin X, Chen J, Jiang Z. Intensifying esterification reaction between lactic acid and ethanol by pervaporation dehydration using chitosan-TEOS hybrid membranes. Chem Engin J 2009; 155:800-809

10. Morpurgo M, Teoli D, Pignatto M, Attrezzi M, Spadaro F, Realdon N. The effect of Na2CO3, NaF and NH4OH on the stability and release behavior of sol-gel derived silica xerogels embedded with bioactive compunds. Acta Biomater 2010; 6:2246-2253

11. Estella J, Echeverría JC, Laguna M, Garrido JJ. Effects of aging and drying conditions on the structural and textural properties of silica gels. Micropor Mesopor Mater 2007; 102:274-282

12. Tsai CH, Lin HJ, Tsai HM, Hwang JT, Chang SM, Chen-Yang YW. Characterization and PEMFC application of a mesoporous sulfonated silica prepared from two precursors, tetraethoxysilane and phenyltriethoxysilane. Int J Hydrogen Energy 2011; 36:9831-9841

13. Estella J, Echeverría JC, Laguna M, Garrido JJ. Silica xerogels of tailored porosity as support matrix for optical chemical sensors. Simultaneous effect of pH, ethanol:TEOS and water:TEOS molar ratios, and synthesis temperature on gelation time, and textural and structural properties. J NonCryst Solids 2007; 353: 286-294

14. Timin AS, Rumyantsev EV. Sol-gel synthesis of mesoporous silicas containing albumin and guanidine polymers and its application to the bilirubin adsorption. J Sol-Gel Sci Technol 2013; 67:297-303

15. Radin S, Chen T, Ducheyne P. The controlled release of drugs from emulsified, solgel processed silica microspheres. Biomaterials 2009; 30: 850-858

16. Dudás Z, Chiriac A, Preda G. Simple entrapment of alcalase in different silica xerogels using the two steps sol-gel method. Annals of West University of Timişoara - Series Chemistry 2011; 20:97-104

17. Tan S, Wu Q, Wang J, et al. Dynamic self-assembly synthesis and controlled release as drug vehicles of porous hollow silica nanoparticles. Micropor Mesopor Mater 2011; 142:601-608

18. Wang Y, Grayson SM. Approaches for the preparation of non-linear amphiphilic polymers and their applications to drug delivery. Adv Drug Deliv Rev 2012; 64:852-865

19. Prow TW, Grice JE, Lin LL, et al. Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev 2011; 63: 470-491

20. Jansen JFGA, Meijer EW, de Brabander-van den Berg EMM. The dendritic box: shape-selective liberation of encapsulated guests. J Am Chem Soc 1995; 117:4417-4418

21. Venkataraman S, Hedrick JL, Ong ZY, et al. The effects of polymeric nanostructure shape on drug delivery. Adv Drug Deliv Rev 2011; 63:1228-1246

22. Mudshinge SR, Deore AB, Patil S, Bhalgat CM. Nanoparticles: Emerging carriers for drug delivery. Saudi Pharm J 2011; 19:129-141

23. Prakash S, Malhotra M, Shao W, Tomaro-Duchesneau C, Abbasi S. Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapy. Adv Drug Deliv Rev 2011; 63:1340-1351

24. Han G, Ghosh P, De M, Rotello VM. Drug and gene delivery using gold nanoparticles. Nanobiotechnol 2007; 3:40-45

25. Janib SM, Moses AS, MacKay JA. Imaging and drug delivery using theranostic nanoparticles. Adv Drug Deliv Rev 2010; 62:1052-1063

26. Lee KY, Yuk SH. Polymeric protein delivery systems. Prog Polym Sci 2007; 32:669-697

27. Suh WH, Suslick KS, Stucky GD, Suh YH. Nanotechnology, nanotoxicology, and neuroscience. Prog Neurobiol 2009; 87:133-170

28. Portney NG, Ozkan M. Nano-oncology: drug delivery, imaging, and sensing. Anal Bioanal Chem 2006; 384:620-630

29. Zalfen AM, Nizet D, Jérôme C, et al. Controlled release of drugs from multi-component biomaterials. Acta Biomater 2008; 4:1788-1796

30. Cheng S, Song Q, Wei D, Gao B. High-level production penicillin G acylase from Alcaligenes faecalis in recombinant Escherichia coli with optimization of carbon sources. Enzyme Microb Technol 2007; 41:326-330

31. Wang F, Saidel GM, Gao J. A mechanistic model of controlled drug release from polymer millirods: effects of excipients and complex binding. Control Release 2007; 119:111-120

32. Machín R, Isasi JR, Vélaz I. Hydrogel matrices containing single and mixed natural cyclodextrins. Mechanisms of drug release. Eur Polym J 2013; 49: 3912-3920

33. Kona S, Dong JF, Liu Y, Tan J, Nguyen KT. Biodegradable nanoparticles mimicking platelet binding as a targeted and controlled drug delivery system. Int J Pharm 2012; 423:516-524

34. Krishnamachari Y, Geary SM, Lemke CD, Salem AK. Nanoparticle delivery systems in cancer vaccines. Pharm Res 2011; 28:215-236

35. Xia W, Chang J, Lin J, Zhu J. The pH-controlled dual-drug release from mesoporous bioactive glass/polypeptide graft copolymer nanomicelle composites. Eur J Pharm Biopharm 2008; 69:546-552

36. Kreye F, Siepmann F, Siepmann J. Drug release mechanisms of compressed lipid implants. Int J Pharm 2011; 404:27-35

37. Tran PHL, Choe JS, Tran TTD, Park YM, Lee BJ. Design and mechanism of on-off pulsed drug release using nonenteric polymeric systems via pH modulation. AAPS PharmSciTech 2011; 12:46-55

38. Hayashi T, Kanbe H, Okada M, et al. Formulation study and drug release mechanism of a new theophylline sustained-release preparation. Int J Pharm 2005; 304: 91-101

39. Yoshida T, Tasaky H, Maeda A, Katsuma M, Sako K, Uchida T. Mechanism of controlled drug release from a salting-out taste-masking system. J Control Release 2008; 131:47-53

40. Fredenberg S, Wahlgren M, Reslow M, Axelsson A. The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems - A review. Int J Pharm 2011; 415:34-52

41. Ferrero C, Massuelle D, Doelker E. Towards elucidation of the drug release mechanism from compressed hydrophilic matrices made of cellulose ethers. II. Evaluation of a possible swelling-controlled drug release mechanism using dimensionless analysis. J Control Release 2010; 141: 223-233

42. Gustavsson A, Bjorkman J, Ljungcrantz C, et al. Pharmaceutical treatment patterns for patients with a diagnosis related to chronic pain initiating slow-release strong opioid treatment in Sweden. Pain 2012; 153:2325-2331

43. Hoya Y, Okamoto T, Yanaga K. Evaluation of analgesic effect and safety of fentanyl transdermal patch for cancer pain as the first line. Support Care Cancer 2010; 18:761-764

44. Kress HG, Von der Laage D, Hoerauf KH, et al. A randomized, open, parallel group, multicenter trial to investigate analgesic efficacy and safety of a new transdermal fentanyl patch compared to standard opioid treatment in cancer pain. J Pain Symptom Manage 2008; 36: 268-279

45. Lane ME. The Transdermal delivery of fentanyl. Eur J Pharm Biopharm 2013; 84:449-455

46. Minkowitz HS. Fentanyl iontophoretic transdermal system: a review. Tech Reg Anesth Pain Managt 2007; 11: 3-8

47. Freynhagen R, von Giesen HJ, Busche P, Sabatowski R, Konrad C, Grond S. Switching from reservoir to matrix systems for the transdermal delivery of fentanyl: a prospective, multicenter pilot study in outpatients with chronic pain. J Pain Symptom Manage 2005; 30:289-297

48. Margetts L, Sawyer R. Transdermal drug delivery: principles and opioid therapy. Contin Educ Anaesth Crit Care Pain 2007; 7:171-176

49. Kress HG, Boss H, Delvin T, et al. Transdermal fentanyl matrix patches Matrifen and Durogesic DTrans are bioequivalent. Eur J Pharm Biopharm 2010; 75:225-231

50. Bajaj S, Whiteman A, Brandner B. Transdermal drug delivery in pain management. Contin Educ Anaesth Crit Care Pain 2011; 11:39-43

51. Coulthard P, Oliver R, Khan Afridi KA, Jackson-Leech D, Adamson L, Worthington H. The efficacy of local anaesthetic for pain after iliac bone harvesting: a randomised controlled trial. Int J Surg 2008; 6:57-63

52. Ilfeld BM, Malhotra N, Furnish TJ, Donohue MC, Madison SJ. Liposomal bupivacaine as a single-injection peripheral nerve block: a dose-response study. Anesth Analg 2013; 117:1248-1256

53. Viscusi ER, Candiotti KA, Onel E, Morren M, Ludbrook GL. The pharmacokinetics and pharmacodynamics of liposome bupivacaine administered via a single epidural injection to healthy volunteers. Reg Anesth Pain Med 2012; 37:616-622

54. Tsuchiya H, Ueno T, Mizogami M, Takakura K. Local anesthetics structure-dependently interact with anionic phospholipid membranes to modify the fluidity. Chem Biol Interact 2010; 183:19-24

55. Shikanov A, Domb AJ, Weiniger CF. Long acting local anesthetic-polymer formulation to prolong the effect of analgesia. J Control Release 2007; 117: 97-103

56. Rodriguez-Navarro AJ, Lagos M, Figueroa C, et al. Potentiation of local anesthetic activity of neosaxitoxin with bupivacaine or epinephrine: development of a long-acting pain blocker. Neurotox Res 2009; 16:408-415.

Journal Information


All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 48 48 15
PDF Downloads 33 33 12